Gilder Gagnon Howe & CO LLC Athenex, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$10.24 - $15.49 $2.28 Million - $3.44 Million	-222,378 Closed	0 $0
Q3 2018 Oct 30, 2018	BUY	$15.53 - $19.97 $1.59 Million - $2.05 Million	102,524 Added 85.54%	222,378 $3.46 Million
Q2 2018 Jul 31, 2018	BUY	$15.88 - $19.5 $1.39 Million - $1.7 Million	87,403 Added 269.34%	119,854 $2.24 Million
Q1 2018 Apr 30, 2018	BUY	$13.53 - $17.47 $439,062 - $566,918	32,451 New	32,451 $552,000
Q4 2017 Jan 31, 2018	SELL	$14.41 - $19.15 $1.28 Million - $1.7 Million	-89,026 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$13.5 - $19.51 $1.2 Million - $1.74 Million	89,026	89,026 $1.56 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.